metazine

The group’s increasing anti-war push shows how progressives are leveraging an unpopular war in the midterms.

President Sadyr Japarov has stifled opposition. Now he’s going after his former right-hand man.

Nikhil Pal Singh on building bigger coalitions and where the opposition goes in this increasingly hostile protest environment.

Researchers at Stanford University modeled how many people could die or be disabled in 25 years if vaccines for polio, measles, rubella or diphtheria were no longer available.

Words considered "woke" are vanishing from National Science Foundation proposals. Grist tracked the changes.

The Trump administration and major refiners are using the war to justify restarting oil production and weakening climate rules.

Thousands more U. S. troops are heading to the Middle East.

There’s still time for a sensible compromise between Washington and Tehran.

U. S. allies worry that Washington will deprioritize Kyiv amid the Iran war.

Lawmakers have concerns about cost, possible ground troops, and unclear objectives.

Jason Bordoff on the winners and losers from conflict in the Middle East.

As the tragedy of murder and destruction unfolds in Iran—and Lebanon, and Palestine—an unbearable farce is simultaneously being staged in the imperial center.

A much-ballyhooed idea is almost—but not quite—dead.

Some ships are getting through: those that pay, and those that play.

A new party takes office with a mandate—and high expectations from the Gen Z movement that propelled it to power.

What a previous intervention reveals about the hard choices that U. S. President Donald Trump faces.

Workplace health and safety policies built around a male default leave millions of women exposed to risks that better regulation could prevent.

Despite being a renewables superpower, China continues to permit and build new coal-fired power plants at a rapid pace. Analysts say the nation’s new five-year plan will ensure further coal plant expansion and jeopardize China’s ability to deliver on its climate promises.

The first accusation against Dr. Mark Mulholland came in January 2022. Two more arrived in 2023 and a fourth in 2024 before the board took action against his license last year. Then even more patients came forward.

The social media warriors have helped make AIPAC a politically toxic brand — and fueled debate over what it means to be "pro-Israel. "